Baxter will share an update on Hurricane Helene’s impact, while Medtronic will likely discuss a new pulsed field ablation ...

The U.S. Food and Drug Administration on Thursday announced a Class 1 recall for Medtronic MiniMed 600- and 700-series insulin pumps because of an increased risk of shorter battery life that could ...

Medtronic MDT underwent analysis by 15 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table provides a quick overview of their recent ...

With this approval, Medtronic is now the first and only company with two PFA technologies available for patients with Afib. The PulseSelect™ Pulsed Field Ablation System, which was FDA approved ...

Progressing the development of a novel CGM sensor to the point where it can improve the quality of life for millions of people with diabetes can be a tall order. In order to build confidence that the ...

The Affera mapping and ablation system with the Sphere-9 catheter [Images courtesy of Medtronic] Medtronic (NYSE:MDT) today said it received FDA approval for its Affera mapping and ablation system ...

Sensors are devices that detect and quantify physical aspects of the world around us. The measurement can either be read directly or converted to a signal for processing by electrical, hydraulic ...

The mainstay of type 1 diabetes mellitus (T1DM) treatment consists of subcutaneous (SC) insulin administration using multiple daily injections (MDI) or continuous subcutaneous insulin infusion ...

It achieves high fluorescence resonance energy transfer contrast and enables tuning of the response window for improved sensor specificity, multiplexing and logic sensing. This study presents P ...

Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology in the Twiist device. Leerink analysts said the results were largely in ...